Improving the Supply of Critical Medications for Pediatric and Adult Cancer Patients

Columbus, OH – August 1, 2024 – STAQ Pharma, a hospital-owned 503B outsourcing supplier committed to alleviating drug shortages, announced the launch of their oncology portfolio at a ceremony held at their Columbus, OH, facility on Friday, July 26. The oncology portfolio begins with methotrexate, an essential treatment widely used for pediatric cancer patients. STAQ Pharma hopes to provide relief for hospital and healthcare system supply chains as an onshore supplier with the release of its first commercial batch of oncology medications.

The successful production of methotrexate comes from their newest manufacturing facility in Columbus, OH, which was specifically designed to produce hazardous drugs such as oncology medications. In addition to the production of essential oncology drugs, the Columbus facility addresses drug shortages in the sterile injectable market. Read more >